Montelukast Prescribing at BANKHOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,125
Total Quantity
27.8K
NHS Cost
£1.4K
vs National Avg
+64.3%
BANKHOUSE SURGERY prescribed 1,125 items of Montelukast over the last 12 months at a cost of £1,356 to the NHS. This is 64.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
96
Jul 2026
74
Jul 2026
101
Jul 2026
88
Jul 2026
94
Jul 2026
96
Jul 2026
95
Jul 2026
103
Jul 2026
109
Jul 2026
80
Jul 2026
91
Jul 2026
98
Prescribing Details
| Total Items | 1,125 |
|---|---|
| Total Quantity | 27,791 |
| Total NHS Cost | £1,356 |
| Presentations | 4 different forms |
| vs National Average | +64.3% |
Montelukast Prescribing Comparison
| This practice | 1,125 items |
|---|---|
| National average per practice | 685 items |
| Difference | +64.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.